Liter VA 2
Liter VA 2
Liter VA 2
Volume 10, Issue 13, 2246-2262. Review Article ISSN 2277– 7105
Manohar Yadav*, Popin Kumar, Yogita Tyagi, Archana Rautela and Praveen Kumar
Ashok
ABSTRACT
Article Received on
21 September 2021, The purpose of this article is to overcome the systemic adverse effect
Revised on 11 October 2021, of fluconazole that is hepatotoxicity and nephrotoxicity by topical
Accepted on 01 Nov. 2021
DOI: 10.20959/wjpr202113-22395
application of fluconazole. Emulsion which are viscous, liquid or
semisolid emulsion is called cream. Fluconazole is an azole antifungal
and used in the treatment of local and systemic fungal infections like
*Corresponding Author
tinea corporis, onychomycosis and dermatophytosis. The topical
Manohar Yadav
formulation is used to introduce the drug into the skin or mucous
Department of Pharmacy,
Gyani Inder Singh Institute membrane of the skin and also for the different skin disorders. For
of Professional Studies, efficient delivery of drug to skin tissue, a fluconazole vanishing cream
Uttarakhand Technical was not developed till date. But we can found various formulations like
University, Dehradun,
fluconazole capsule, tablets etc. Skin creams are generally W/O and
Uttarakhand, India.
O/W. In the skin creams various vitamins like vit. A, E and D3 and
fatty acid used. The main objective of the study is to treat fungal
infections. Fungal infection is very common and can affect persons of all ages. So,
Fluconazole vanishing cream formulation was developed in this study and is promising for
better patient compliance as no any traces when applied.
INTRODUCTION
A vanishing cream is a cream with low fat moisturizer that disappears into the skin. It softens
skin, leaving nothing behind. It is perhaps the commonest prescribed topical medicament. As
it is less oily, messy and sticky, most patients find it more user-friendly.[1] Fungal infection
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2246
Yadav et al. World Journal of Pharmaceutical Research
son scalf are common and some of them causes serious illness. The scalf infections such as
Tinea vesicular, (pityriasis, versicolar), Seborrhea dermatitis, pityriasis capititis have been
mentioned as a scaling disorders, will affect scalf and hair abruptly. The genus malassezia
responsible for variety of superficial cutaneous as well as systemic fungal infections and
pityriasis versicolor is the most commonly presenting diseases.[2]
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2247
Yadav et al. World Journal of Pharmaceutical Research
Types of cream
1. Oil in water (o/w) cream, example. Vanishing cream
2. Water in oil (w/o) cream, example. Cold cream
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2248
Yadav et al. World Journal of Pharmaceutical Research
Physiological Properties
Non irritating
Do not alter membrane / skin functioning
Miscible with skin secretion
Have low sensitization index
Application Properties
Easily applicable with efficient drug release
High aqueous washability
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2249
Yadav et al. World Journal of Pharmaceutical Research
Functions of skin
Skin protects from external and internal environment.
It contain body fluid and and tissues.
It protects from external stimuli like pollution, chemicals, light, radiation, heat, cold,
It helps in the synthesis of biochemical.
It helps in metabolism and disposal of biochemical wastes.
It helps to maintain body temperature and controlling of blood pressure.
It also works as cushions against mechanical shock.
It helps to prevents from loss of moisture.
It reduces harmful effects of UV radiation.
Skin also acts as a sensory organ (touch, feel, detects temperature).
It helps to regulate body temperature.
Skin also works as an immune organ which detects infections etc.
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2250
Yadav et al. World Journal of Pharmaceutical Research
BIOCHEMISTRY OF SKIN
Epidermis
The outer layer of skin which acts water-proof barrier of the body is known as epidermis.
Squamous epithelial tissue having four kinds of cells is composed of the epidermis layer of
skin. Marker cells, Langerhans, Melanocytes and last one is keratinocytes. Our body or
internal organ through the external environmental condition such as microbes and other
external elements is protected by epidermal layer. To produce keratin protein which helps to
keep safe the skin and tissue from heat, microbes and other external chemicals keratinocytes
of epidermal layer are responsible. Source of energy for the lower portion of epidermis and
lactic acid is end product of the metabolism that accumulates in the skin is glucose. For the
pigmentation of skin and brown- black and yellow-red pigment melanin is liable. Melanin
supply skin color is produced by melanocytes of epidermal layer. Stratum basal, stratum
granulose, stratum spin sum, stratum lucidum and stratum corneum fifth layer present in the
epidermal cells as. The entire cellular make-up changes during differentiation from basal
cells to stratum conium by degradation of the existing cellular components. Host enzyme of
lysosomes an release for intracellular lies is lytic enzymes and the epidermis is reservoir.[8-11]
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2251
Yadav et al. World Journal of Pharmaceutical Research
DERMIS
Beneath the epidermis layer and subcutaneous layer the inner layer of skin which is found is
known as dermis and despite its larger area of skin, Cellular and a cellular structure is
comprising by dermis and composed of hair follicles, blood vessels, nerve, amorphous and
fibrous connective tissue, dermal cells and receptors. Due to dermal papillae the surface area
of dermis is large. For Several cell types including multi-functional cells of the immune
system like macrophages and mast cells the dermis is home.[12,13]
Hypodermis
Hypodermis layer composed of the cells called adipose tissue, fibroblast, fat cells,
microphages and blood vessels. Hypodermis layer is made up of areolar and adipose
tissue.[14]
R=H/FDK
R =Resistance of diffusion resistor
H = Thickness
F = Fractional area
K = Relative capacity
D = diffusivity
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2252
Yadav et al. World Journal of Pharmaceutical Research
Penetration enhancer
Chemical penetration enhancer
These are classified into following types:
Solvents
For penetration enhancer solvents play an important role. Increased penetration of these
compounds possibly by pump the polar pathway and/or by fluidizing lipids. Propylene glycol,
isopropyl alcohol, glycerin, transcutol-p, water, alcohols, methanol and ethanol.
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2253
Yadav et al. World Journal of Pharmaceutical Research
Anionic surfactant
Surfactants having negative charge on their hydrophilic head that responds to provide
excellent detergency properties due to ability to bind positive charge particles are known as
anionic surfactant. Interact strongly with skin theses surfactant can penetrate. Some examples
of anionic surfactants include are alkyl ether sulfates, sodium dodecyl sulfate, benzyl
sulfonates, Decodecylmethyl sulphoxide, Sodium lauryl sulphate etc.[30]
Cationic surfactant
These having negative charge on their water loving head unlike to anionic surfactants but is
not widely used as skin penetration enhancer so these are known as cationic surfactant.
Examples: Dodecyl trimethyl ammonium chloride.
Non-ionic surfactant
Examples include: castor oil ethoxylate amines, Pluronic F68 etc.
Binary system
Examples are 1, 4-butane diol- linoleic acid and Prolylene glycol -oleic acid.
Miscellaneous chemicals
Miscellaneous includes N, N-dimethyl-m-toluidine, urea, calcium thioglycolate etc.
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2254
Yadav et al. World Journal of Pharmaceutical Research
Release characteristics
In the drug release system, the drug molecules are dissolved or suspended in the delivery
system release of drugs depends. From delivery systems to the skin pH of the vehicle the
interfacial partition coefficient of drug.
Penetration enhancer
These can be achieved by two ways either by chemical enhancer or by physical method.
Anionic surfactant
Surfactants having negative charge on their hydrophilic head that responds to provide
excellent detergency properties due to ability to bind positive charge particles are known as
anionic surfactant. Interact strongly with skin theses surfactant can penetrate. Some examples
of anionic surfactants include are alkyl ether sulfates, sodium dodecyl sulfate, benzyl
sulfonates, Decodecylmethyl sulphoxide, Sodium lauryl sulphate, etc.[26]
Cationic surfactant
These having negative charge on their water loving head unlike to anionic surfactants but is
not widely used as skin penetration enhancer so these are known as cationic surfactant.
Examples: Dodecyl trimethyl ammonium chloride.
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2255
Yadav et al. World Journal of Pharmaceutical Research
Non-ionic surfactant
Least potential for irritation are the properties of non-ionic surfactant.
Examples include: castor oil ethoxylate, Ethoxylated amines, and Pluronic F68 etc.
Binary system
Binary system, heterogeneous multilaminated pathway as well as the continuous pathways
these systems apparently include. Examples are 1,4-butane dial- linoleic acid and Propylene
glycol -oleic acid.
Miscellaneous chemicals
Miscellaneous includes N, N-dimethyl-m-toluidine, urea, calcium thioglycolate etc.
Phonophoresis
Phonophoresis is the movement of drugs through living intact skin and into soft tissues under
the ultrasound application is called phonophoresis.
Sonophoresis
In this process, the drug delivery process that involves the usage of the ultrasound waves is
called sonophoresis. In permeation of low frequency ultrasound the ultrasound application
has resulted was shown to increase the permeability of human skin by several orders of
magnitude too many drugs are included high molecular weight.
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2256
Yadav et al. World Journal of Pharmaceutical Research
EVALUATION PARAMETER
Identification of Drug
IR Spectroscopy
Solubility Studies of drug molecules
Melting Point determination
Partition-Coefficient
Compatibility Studies of drug
Physical Identification of Drug
Partition Coefficient
In this, Partition coefficient is used to identify the hydrophilic/Lipophilic nature of drug
molecules which can affect extend of drug absorption as well as the rate of absorption of
drug. By the lipophilicity, the partition coefficient of drug is measured and it also have the
tendency to cross biological membrane. The log p value of lipophilic drug is much greater
than 1 and the hydrophilic drugs has partition coefficient value always less than 1.
Pw/o = (C aqueous/ organic)
Po/w = (C organic/C aqueous)
For partition coefficient using n-Octanol/ buffer and n-Octanol/ water general procedure
should followed and at the 250nm the absorbance was taken.
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2257
Yadav et al. World Journal of Pharmaceutical Research
PH of the formulation
The pH of formulation was measured by using Ph. meter or Ph. paper.[27], [28], [29]
Drug content
The drug content was determined by UV Spectrophotometry.
Kinetics of permeation
For the development of topical formulation, knowledge of skin permeation plays the vital to
the successful development.
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2258
Yadav et al. World Journal of Pharmaceutical Research
Candida krusei
Frequent use of fluconazole can select for the emergence of Candida krusei as a commonly
isolated opportunistic pathogen in some medical centers. Frequent use of fluconazole cause
Candida Krusei.(7)
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2259
Yadav et al. World Journal of Pharmaceutical Research
CONCLUSION
The drug more efficiently to skin tissue such as the epidermis, stratum corneum and dermis
when topical formulation of Fluconazole was demonstrated to be able to deliver. Therefore,
the topical formulation of fluconazole is promising for the treatment of cutaneous mycoses
caused by dermatophytes and other dermatophytosis, Candida krusei, Candida glabrata etc.
REFERENCES
1. Davis, Surver, C. and F.A., Bioequivalence and bioavaibility, In Walter, K.A.,
Transdermal Formulation and dermatological, INC. Marcal Dekker, NewYork, 119,
2002, pp. 403, 326,327, 323,403.
2. Ansel H.C., “Drug Delivery System" 7th edition, Wilkens Baltimore, 2000, 249-251,
244-246, 253-255,264-265.
3. Nkhat P.D., Nayank S.H., and Yeole P.G., “The Indian Pharmacist”, Sept. 2004; III(27):
7-14.
4. Jain N.K., Et. al., “The Pharma Times”, May 2000, 21.
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2260
Yadav et al. World Journal of Pharmaceutical Research
5. Misra A.N., “Novel Drug Delivery”, CBS Distributors and Publishers, New Delhi, 1997;
107-109.
6. Mishra B., Kumari P. and “The Indian Pharmacist”, Jun. 2004; III(24): 7-16.
7. Jain N.K., Et. al., “The Pharma Times”, May 2000; 21.
8. Rodes C.T., Banker G.B.S., “The Modern Pharmacist”, 2nd edition, Vol. 40, New York,
Marcel Dekker, 1979; 263-273, 283,285-287,299-311.
9. Robinson J.R., and Lee V.H.L., “J. Pharma. Sci.” 1979; 68, and 673.
10. Lemberger A.P., “Hand Book of Non Prescription of Drug”, Pharmaceutical Association
of America, Washington, 1973; 161.
11. Buettner K.J.K., Rushmer R.F., “Odland, Science”, 1966; 343, 154.
12. Jaain N.K., “Novel Drug Delivery and controlled”, Ist edition, CBS Distributors and
Publishers, Delhi, 1997; 100-106.
13. Stewart S., Storm J.E., Collier S.W., “During Percutaneous Penetration mtabolism of
xenobiotics: Cutaneous Enzyme Activity and role of Absorption Rate, Fundam. Appl.
Toxicol”, 1990; 132 –41.
14. Mishra A.N., “Novel Drug Delivery and controlled Drug Delivery System”, CBS
Distributors and Publisherss, New Delhi, 1997; 107-109.
15. Lemberger A.P., “Non Prescription Drug a hand book”, Association of American
Pharmaceutical, Washington, 1973.
16. Lemberger A.P., “Hand Book of Non Prescription of Drug”, Pharmaceutical Association
of America, Washington, 1973; 161.
17. Williams R, Clinical Pharmacological, Penetration Enhancement”, 1993; 27-35.
18. A Block L.H. “Remington -Practice of Pharmacy and the science”, I volume, 21st edition,
Wilkins and Lippincott Williams, 2006; 875-877.
19. Kanig J.C, Lieberman H.A., “Practice of Industrial Pharmacy and the theory”, IIIrd
edition, 1991, Varghnese Publishing House, 615-618.
20. A Ecleston G.M. “Pharmaceutical Technology of Encyclopedia”, Vol 9, Dekkes and
Marcel, New York, 1992; 375-421.
21. A Jain N.K., “Novel Drug Delivery and Controlled drug delivery system”, Ist edition,
CBS Distributors and Publishers, Delhi, 1997; 100-106.
22. Saha R.N., and Mithal B.M., “Cosmetics Hand book”, Ist edition, Vallabh Prakashan
Delhi, 2003; 11-17,237-38, 1-22,61-89,90-93,177,214-215.
23. Bose V.G., and Prausnitz M.R. “Electroporation: In Percutaneous Penetration
Enhancers”, Bocaraton, CRC Press, 1995; 393-405.
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2261
Yadav et al. World Journal of Pharmaceutical Research
24. A Block L.H. “Remington -The Practice of Pharmacy and science”, I volume, 21st
edition, Wilkins and Lippincott Williams, 2006; 875-877.
25. Nkhat P.D., Nayank S.H., and Yeole P.G., “The Indian Pharmacist”, Sept. 2004; III(27):
7-14.
26. Jels and Jellies, Klich CM, Technology of Encyclopedia Pharmaceutical. New York, NY:
Marcel Dekker Inc., 1992; 6: 415- 39.
27. Ganesan M, Devi US, Manavalan R. evaluation and design of tetracycline hydrochloride
gels. Indian Drug, 2002; 39(10): 552-4.
28. Ghafourian T, Nazemiyeh H, Nokhodchi A, Hassan- Zadeh D, Bahary LAS. IL Farmaco,
2002; 57: 883-8.
29. Gibaly EI, Shaltout SE Fetih GN. Int J Pharm, 2004; 276: 11-28.
30. A Mohamed MI. Chlorphenesin emulgel formulation of optimization. The AAPS Journal,
2004; 6(3): 1-7.
31. Grant SM, Fluconazole Drugs, 1990 Jun; 39(6): 877-916.
32. Barradell LB., Goa Kl, Fluconazole Drugs, 1995 Oct; 50(4): 658-90.
33. Ryckelynck, Jp. Clinical, Venkatakrishna K, pharmacokinetics, 1993 Jan; 24(1): 10-27.
34. Meunier F Zervos M,. Fluconazole (Diflucan®:a International journal review of
antimicrobials agents, 1993 Jan 1; 3(3): 147-70.
www.wjpr.net │ Vol 10, Issue 13, 2021. │ ISO 9001:2015 Certified Journal │ 2262